262 related articles for article (PubMed ID: 28887549)
1. SATB2/β-catenin/TCF-LEF pathway induces cellular transformation by generating cancer stem cells in colorectal cancer.
Yu W; Ma Y; Shankar S; Srivastava RK
Sci Rep; 2017 Sep; 7(1):10939. PubMed ID: 28887549
[TBL] [Abstract][Full Text] [Related]
2. SATB2 is a novel biomarker and therapeutic target for cancer.
Roy SK; Shrivastava A; Srivastav S; Shankar S; Srivastava RK
J Cell Mol Med; 2020 Oct; 24(19):11064-11069. PubMed ID: 32885593
[TBL] [Abstract][Full Text] [Related]
3. Role of SATB2 in human pancreatic cancer: Implications in transformation and a promising biomarker.
Yu W; Ma Y; Shankar S; Srivastava RK
Oncotarget; 2016 Sep; 7(36):57783-57797. PubMed ID: 27472393
[TBL] [Abstract][Full Text] [Related]
4. Special AT-rich sequence-binding protein 2 acts as a negative regulator of stemness in colorectal cancer cells.
Li Y; Liu YH; Hu YY; Chen L; Li JM
World J Gastroenterol; 2016 Oct; 22(38):8528-8539. PubMed ID: 27784965
[TBL] [Abstract][Full Text] [Related]
5. Chronic alcohol exposure induces hepatocyte damage by inducing oxidative stress, SATB2 and stem cell-like characteristics, and activating lipogenesis.
Yu W; Ma Y; Shrivastava SK; Srivastava RK; Shankar S
J Cell Mol Med; 2022 Apr; 26(7):2119-2131. PubMed ID: 35152538
[TBL] [Abstract][Full Text] [Related]
6. Cellular transformation of human mammary epithelial cells by SATB2.
Yu W; Ma Y; Ochoa AC; Shankar S; Srivastava RK
Stem Cell Res; 2017 Mar; 19():139-147. PubMed ID: 28167342
[TBL] [Abstract][Full Text] [Related]
7. SPDEF Induces Quiescence of Colorectal Cancer Cells by Changing the Transcriptional Targets of β-catenin.
Lo YH; Noah TK; Chen MS; Zou W; Borras E; Vilar E; Shroyer NF
Gastroenterology; 2017 Jul; 153(1):205-218.e8. PubMed ID: 28390865
[TBL] [Abstract][Full Text] [Related]
8. BCL-3 promotes a cancer stem cell phenotype by enhancing β-catenin signalling in colorectal tumour cells.
Legge DN; Shephard AP; Collard TJ; Greenhough A; Chambers AC; Clarkson RW; Paraskeva C; Williams AC
Dis Model Mech; 2019 Mar; 12(3):. PubMed ID: 30792270
[TBL] [Abstract][Full Text] [Related]
9. RNA binding protein RBM3 increases β-catenin signaling to increase stem cell characteristics in colorectal cancer cells.
Venugopal A; Subramaniam D; Balmaceda J; Roy B; Dixon DA; Umar S; Weir SJ; Anant S
Mol Carcinog; 2016 Nov; 55(11):1503-1516. PubMed ID: 26331352
[TBL] [Abstract][Full Text] [Related]
10. Higher expression of SATB2 in hepatocellular carcinoma of African Americans determines more aggressive phenotypes than those of Caucasian Americans.
Yu W; Roy SK; Ma Y; LaVeist TA; Shankar S; Srivastava RK
J Cell Mol Med; 2019 Dec; 23(12):7999-8009. PubMed ID: 31602781
[TBL] [Abstract][Full Text] [Related]
11. SATB1 and SATB2 play opposing roles in c-Myc expression and progression of colorectal cancer.
Mansour MA; Hyodo T; Akter KA; Kokuryo T; Uehara K; Nagino M; Senga T
Oncotarget; 2016 Jan; 7(4):4993-5006. PubMed ID: 26701851
[TBL] [Abstract][Full Text] [Related]
12. Low-grade slightly elevated and polypoid colorectal adenomas display differential β-catenin-TCF/LEF activity, c-Myc, and cyclin D1 expression.
Yang TW; Gao YH; Ma SY; Wu Q; Li ZF
World J Gastroenterol; 2017 May; 23(17):3066-3076. PubMed ID: 28533663
[TBL] [Abstract][Full Text] [Related]
13. Metformin reduces SATB2-mediated osteosarcoma stem cell-like phenotype and tumor growth via inhibition of N-cadherin/NF-kB signaling.
Xu HY; Fang W; Huang ZW; Lu JC; Wang YQ; Tang QL; Song GH; Kang Y; Zhu XJ; Zou CY; Yang HL; Shen JN; Wang J
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4516-4528. PubMed ID: 29131265
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of E-cadherin is an essential event in activating beta-catenin/Tcf-dependent transcription and expression of its target genes in Pdcd4 knockdown cells.
Wang Q; Sun ZX; Allgayer H; Yang HS
Oncogene; 2010 Jan; 29(1):128-38. PubMed ID: 19784072
[TBL] [Abstract][Full Text] [Related]
15. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
[TBL] [Abstract][Full Text] [Related]
16. E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced beta-catenin-Tcf/Lef-dependent transcription.
Torres VA; Tapia JC; Rodriguez DA; Lladser A; Arredondo C; Leyton L; Quest AF
Mol Cell Biol; 2007 Nov; 27(21):7703-17. PubMed ID: 17785436
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of C-terminal binding protein attenuates transcription factor 4 signaling to selectively target colon cancer stem cells.
Patel J; Baranwal S; Love IM; Patel NJ; Grossman SR; Patel BB
Cell Cycle; 2014; 13(22):3506-18. PubMed ID: 25483087
[TBL] [Abstract][Full Text] [Related]
18. Beta-catenin/Tcf-4 inhibition after progastrin targeting reduces growth and drives differentiation of intestinal tumors.
Pannequin J; Delaunay N; Buchert M; Surrel F; Bourgaux JF; Ryan J; Boireau S; Coelho J; Pélegrin A; Singh P; Shulkes A; Yim M; Baldwin GS; Pignodel C; Lambeau G; Jay P; Joubert D; Hollande F
Gastroenterology; 2007 Nov; 133(5):1554-68. PubMed ID: 17920061
[TBL] [Abstract][Full Text] [Related]
19. UCHL1 acts as a colorectal cancer oncogene via activation of the β-catenin/TCF pathway through its deubiquitinating activity.
Zhong J; Zhao M; Ma Y; Luo Q; Liu J; Wang J; Yuan X; Sang J; Huang C
Int J Mol Med; 2012 Aug; 30(2):430-6. PubMed ID: 22641175
[TBL] [Abstract][Full Text] [Related]
20. SATB2 suppresses the progression of colorectal cancer cells via inactivation of MEK5/ERK5 signaling.
Mansour MA; Hyodo T; Ito S; Kurita K; Kokuryo T; Uehara K; Nagino M; Takahashi M; Hamaguchi M; Senga T
FEBS J; 2015 Apr; 282(8):1394-405. PubMed ID: 25662172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
